Literature DB >> 23340221

Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin.

Ethel Antunes Wilhelm1, Cristiano Ricardo Jesse, Cristiani Folharini Bortolatto, Cristina Wayne Nogueira.   

Abstract

The present study was designed to examine the correlations between behavioural and oxidative parameters in a quinolinic acid model of Huntington's disease in rats. The protective effect of melatonin against the excitotoxicity induced by quinolinic acid was investigated. Rats were pre-treated with melatonin (5 or 20mg/kg) before injection of quinolinic acid (240nmol/site; 1μl) into their right corpora striata. The locomotor and exploratory activities as well as the circling behaviour were recorded. The elevated body swing test was also performed. After behavioural experiments, biochemical determinations were carried out. Melatonin partially protected against the increase of circling behaviour caused by quinolinic acid injection. No alteration was found in the number of crossings and rearings of animals treated with melatonin and/or quinolinic acid. Melatonin decreased the percentage of contralateral biased swings induced by quinolinic acid. Melatonin protected against the increase in reactive species and protein carbonyl levels as well as the inhibition of superoxide dismutase activity resulting from quinolinic acid injection. Melatonin was partially effective against the inhibition of striatal catalase activity and a decrease of non-protein thiol levels induced by quinolinic acid. Melatonin was not effective against the inhibition of Na(+), K(+) ATPase activity caused by quinolinic acid injection. There were significant correlations between circling behaviour and oxidative parameters. The antioxidant property of melatonin is involved, at least in part, in its neuroprotective effect. The results reinforce the idea that melatonin could be useful in overwhelming neurotoxicity caused by quinolinic acid, a rat model of Huntington's disease.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340221     DOI: 10.1016/j.ejphar.2013.01.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.

Authors:  Priyanka Saroj; Yashika Bansal; Raghunath Singh; Ansab Akhtar; Rupinder Kaur Sodhi; Mahendra Bishnoi; Sangeeta Pilkhwal Sah; Anurag Kuhad
Journal:  Inflammopharmacology       Date:  2021-01-31       Impact factor: 4.473

2.  Worsening Choreoathetosis in Huntington's Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report.

Authors:  Clayton J Hamilton; Tysen K Timmer; Robert C Munjal; Fernando Cardozo-Pelaez; Ian R Mcgrane
Journal:  Innov Clin Neurosci       Date:  2018-08-01

3.  Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits.

Authors:  Xiaowen Cheng; Yufeng Wan; Yuanhong Xu; Qing Zhou; Yuan Wang; Huaqing Zhu
Journal:  Mol Med Rep       Date:  2014-10-23       Impact factor: 2.952

Review 4.  Role of melatonin in traumatic brain injury and spinal cord injury.

Authors:  Mehar Naseem; Suhel Parvez
Journal:  ScientificWorldJournal       Date:  2014-12-21

5.  Protein kinase C is involved in the neuroprotective effect of berberine against intrastriatal injection of quinolinic acid-induced biochemical alteration in mice.

Authors:  Peng Liu; Yinjie Li; Xiaoxiao Qi; Jia Xu; Danyang Liu; Xuefei Ji; Tianyan Chi; Han Liu; Libo Zou
Journal:  J Cell Mol Med       Date:  2019-07-18       Impact factor: 5.310

6.  Hyperphosphorylation of Tau Due to the Interference of Protein Phosphatase Methylesterase-1 Overexpression by MiR-125b-5p in Melatonin Receptor Knockout Mice.

Authors:  Han Zhao; Lingyan Feng; Wei Zhong; Hongyan Zhen; Qingjia Chi; Xiang Wang
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

Review 7.  Quinolinic acid: an endogenous neurotoxin with multiple targets.

Authors:  Rafael Lugo-Huitrón; Perla Ugalde Muñiz; Benjamin Pineda; José Pedraza-Chaverrí; Camilo Ríos; Verónica Pérez-de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2013-09-05       Impact factor: 6.543

8.  Saliva cortisol, melatonin levels and circadian rhythm alterations in Chinese primary school children with dyslexia.

Authors:  Yanhong Huang; Chongtao Xu; Meirong He; Wenlong Huang; Kusheng Wu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.